Structural analysis of substrate and effector binding in Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase

被引:30
作者
Dey, Sanghamitra [3 ]
Burton, Rodney L. [1 ]
Grant, Gregory A. [1 ,2 ]
Sacchettini, James C. [3 ]
机构
[1] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[3] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA
关键词
D O I
10.1021/bi800212b
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The crystal structure of Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase has been solved with bound effector, L-serine, and substrate, hydroxypyruvic acid phosphate, at resolutions of 2.7 and 2.4 angstrom, respectively. The subunits display the same extreme asymmetry as seen in the apostructure and provide insight into the mode of serine binding and closure of the active site. Mutagenesis studies confirm the identity of the main residues involved in serine binding and suggest that the poly glycine stretch in the loop that contains the locus for the 160 degrees rotation that leads to subunit asymmetry may have a larger role in folding than in catalysis. The lack of electron density for the cofactor, NADH, in any of the crystals examined led us to study binding by stopped flow kinetic analysis. The kinetic data suggest that productive NADH binding, that would support catalytic turnover, is dependent on the presence of substrate. This observation, along with the binding of substrate in the active site, but in an unproductive conformation, suggests a possible mechanism where initial binding of substrate leads to enhanced interaction with cofactor accompanied by a rearrangement of catalytically critical residue side chains. Furthermore, comparison to the structure of a truncated form of human D-3-phosphoglycerate dehydrogenase with cofactor and a substrate analog, provides insight into the conformational changes that occur during catalysis.
引用
收藏
页码:8271 / 8282
页数:12
相关论文
共 34 条
[1]   Cloning, sequencing and expression of rat liver 3-phosphoglycerate dehydrogenase [J].
Achouri, Y ;
Rider, MH ;
VanSchaftingen, E ;
Robbi, M .
BIOCHEMICAL JOURNAL, 1997, 323 :365-370
[2]   The mechanism of velocity modulated allosteric regulation in D-3-phosphoglycerate dehydrogenase - Site-directed mutagenesis of effector binding site residues [J].
AlRabiee, R ;
Zhang, YP ;
Grant, GA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (38) :23235-23238
[3]  
BELL JE, 1988, PROTEINS ENZYMES, P465
[4]   Multiconformational states in phosphoglycerate dehydrogenase [J].
Bell, JK ;
Grant, GA ;
Banaszak, LJ .
BIOCHEMISTRY, 2004, 43 (12) :3450-3458
[5]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[6]   A novel mechanism for substrate inhibition in mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase [J].
Burton, Rodney L. ;
Chen, Shawei ;
Xu, Xiao Lan ;
Grant, Gregory A. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (43) :31517-31524
[7]   Nucleotide sequence and differential expression of the human 3-phosphoglycerate dehydrogenase gene [J].
Cho, HM ;
Jun, DY ;
Bae, MA ;
Ahn, JD ;
Kim, YH .
GENE, 2000, 245 (01) :193-201
[8]  
Cleland W W, 1979, Methods Enzymol, V63, P500
[9]  
CORMACK B, 1991, CURRENT PROTOCOLS MO
[10]   Crystal structure of Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase [J].
Dey, S ;
Grant, GA ;
Sacchettini, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (15) :14892-14899